apexigen.comHealthcare / BioTech & PharmaFounded: 2010Funding to Date: $165.38MM
Apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by APXiMAB™, the Company’s proprietary antibody drug discovery platform.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/24/2020 | Series C | $127.86MM | $xx.xx | $343.82MM | 3e Bioventures Capital, Decheng Capital, Delian Capital, Efung Capital, H&Q Asia Pacific, Hua Nan Venture Capital, Ldv Ventures, Oceanpine Capital, Shangbay Capital, Sv Tech Ventures, Vi Ventures | |
Price per Share
$xx.xx
Shares Outstanding
82,503,347
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
3e Bioventures Capital, Decheng Capital, Delian Capital, Efung Capital, H&Q Asia Pacific, Hua Nan Venture Capital, Ldv Ventures, Oceanpine Capital, Shangbay Capital, Sv Tech Ventures, Vi Ventures
|
||||||
08/08/2018 | Series B | $15MM | $xx.xx | $115.22MM | Decheng Capital, Trans-Pacific Technology Fund | |
Price per Share
$xx.xx
Shares Outstanding
14,218,546
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Decheng Capital, Trans-Pacific Technology Fund
|
||||||
08/08/2013 | Series A-2 | $2.53MM | $xx.xx | $48.43MM | Amkey Ventures, China Development Industrial Bank, Sycamore Ventures, Themes Investment Partners, Wsr Capital | |
Price per Share
$xx.xx
Shares Outstanding
12,652,762
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Amkey Ventures, China Development Industrial Bank, Sycamore Ventures, Themes Investment Partners, Wsr Capital
|
||||||
08/08/2013 | Series A-1 | $19.99MM | $xx.xx | $48.43MM | Amkey Ventures, China Development Industrial Bank, Sycamore Ventures, Themes Investment Partners, Wsr Capital | |
Price per Share
$xx.xx
Shares Outstanding
39,196,116
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
2
Key Investors
Amkey Ventures, China Development Industrial Bank, Sycamore Ventures, Themes Investment Partners, Wsr Capital
|